Live Breaking News & Updates on Clinical Development At Intermune

Stay updated with breaking news from Clinical development at intermune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders

PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders Leading experts in the field will advise on clinical development of PureTech’s lead, wholly-owned product candidate, LYT-100, in idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lu. ....

United States , Bill Bradford , Claude Bernard Lyon , Marlies Wijsenbeek , Toby Maher , Vincent Cottin , Daphne Zohar , Paul Noble , Kevin Flaherty , Sinai Medical Center , Genentech Inc , University Of Michigan , Puretech Health , Coordinator Of The National Coordinating Reference Center , Erasmus Medical Center , Department Of Medicine , Boehringer Ingelheim International Gmb , Clinical Development At Intermune , Puretech Forms Clinical Advisory Board , Idiopathic Pulmonary Fibrosis , Related Lung , Tech Health , Clinical Advisory Board , Chief Executive Officer , Senior Vice President , Clinical Development ,

PureTech Health plc: PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders

PureTech Health plc: PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders
idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ( PureTech or the Company ), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced the formation of its Clinical Advisory Board for idiopathic pulmonary fibrosis (IPF) and other progressive fibrosing interstitial lung diseases (PF-ILDs). Comprised of physicians and researchers with deep expertise in the clinical development of novel therapies in PF-ILDs, the advisory group will work closely with PureTech as it advances LYT-100 (deupirfenidone). ....

United States , Bill Bradford , Claude Bernard Lyon , Marlies Wijsenbeek , Toby Maher , Vincent Cottin , Allison Mead Talbot , Daphne Zohar , Stephanie Simon , Paul Noble , Kevin Flaherty , Sinai Medical Center , Genentech Inc , University Of Michigan , Puretech Health , Coordinator Of The National Coordinating Reference Center , Erasmus Medical Center , Department Of Medicine , Boehringer Ingelheim International Gmb , Clinical Development At Intermune , Tech Health , Clinical Advisory Board , Business Wire , Chief Executive Officer , Senior Vice President , Clinical Development ,